These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 25605045)
1. Does combined clinical and ultrasound assessment allow selection of individuals with rheumatoid arthritis for sustained reduction of anti-tumor necrosis factor therapy? Marks JL; Holroyd CR; Dimitrov BD; Armstrong RD; Calogeras A; Cooper C; Davidson BK; Dennison EM; Harvey NC; Edwards CJ Arthritis Care Res (Hoboken); 2015 May; 67(6):746-53. PubMed ID: 25605045 [TBL] [Abstract][Full Text] [Related]
2. Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Naredo E; Möller I; Cruz A; Carmona L; Garrido J Arthritis Rheum; 2008 Aug; 58(8):2248-56. PubMed ID: 18668537 [TBL] [Abstract][Full Text] [Related]
3. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission? Alivernini S; Tolusso B; Petricca L; Bui L; Di Sante G; Peluso G; Benvenuto R; Fedele AL; Federico F; Ferraccioli G; Gremese E Ann Rheum Dis; 2017 Jul; 76(7):1228-1236. PubMed ID: 28119289 [TBL] [Abstract][Full Text] [Related]
4. Prediction of relapse after discontinuation of biologic agents by ultrasonographic assessment in patients with rheumatoid arthritis in clinical remission: high predictive values of total gray-scale and power Doppler scores that represent residual synovial inflammation before discontinuation. Iwamoto T; Ikeda K; Hosokawa J; Yamagata M; Tanaka S; Norimoto A; Sanayama Y; Nakagomi D; Takahashi K; Hirose K; Sugiyama T; Sueishi M; Nakajima H Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1576-81. PubMed ID: 24515410 [TBL] [Abstract][Full Text] [Related]
5. Power Doppler ultrasound monitoring of response to anti-tumour necrosis factor alpha treatment in patients with rheumatoid arthritis. Iagnocco A; Finucci A; Ceccarelli F; Perricone C; Iorgoveanu V; Valesini G Rheumatology (Oxford); 2015 Oct; 54(10):1890-6. PubMed ID: 26070937 [TBL] [Abstract][Full Text] [Related]
6. Presence of power Doppler synovitis in rheumatoid arthritis patients with synthetic and/or biological disease-modifying anti-rheumatic drug-induced clinical remission: experience from a Chinese cohort. Geng Y; Han J; Deng X; Zhang Z Clin Rheumatol; 2014 Aug; 33(8):1061-6. PubMed ID: 24777468 [TBL] [Abstract][Full Text] [Related]
7. Semi-quantitative analysis of rheumatoid finger joint synovitis using power Doppler ultrasonography: when to perform follow-up study after treatment consisting mainly of antitumor necrosis factor alpha agent. Kamishima T; Sagawa A; Tanimura K; Shimizu M; Matsuhashi M; Shinohara M; Hagiwara H; Henmi M; Narita A; Terae S; Shirato H Skeletal Radiol; 2010 May; 39(5):457-65. PubMed ID: 19936743 [TBL] [Abstract][Full Text] [Related]
8. Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission? Janta I; Valor L; De la Torre I; Martínez-Estupiñán L; Nieto JC; Ovalles-Bonilla JG; Martínez-Barrio J; Bello N; Hinojosa M; Montoro M; González CM; López-Longo J; Monteagudo I; Carreño L; Naredo E Rheumatol Int; 2016 Mar; 36(3):387-96. PubMed ID: 26712373 [TBL] [Abstract][Full Text] [Related]
9. Musculoskeletal ultrasound as a biomarker of remission - results from a one-year prospective study in patients with rheumatoid arthritis. Sapundzhieva T; Karalilova R; Batalov A Med Ultrason; 2018 Dec; 20(4):453-460. PubMed ID: 30534652 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of abatacept tapering therapy for sustained remission in patients with rheumatoid arthritis: Prospective single-center study. Yoshida S; Kotani T; Kimura Y; Matsumura Y; Yoshikawa A; Tokai N; Ozaki T; Nagai K; Takeuchi T; Makino S; Arawaka S Int J Rheum Dis; 2019 Jan; 22(1):81-89. PubMed ID: 30168272 [TBL] [Abstract][Full Text] [Related]
11. Subclinical synovitis measured by ultrasound in rheumatoid arthritis patients with clinical remission induced by synthetic and biological modifying disease drugs. Cruces M; Al Snih S; Serra-Bonett N; Rivas JC Reumatol Clin (Engl Ed); 2019; 15(4):218-222. PubMed ID: 29032909 [TBL] [Abstract][Full Text] [Related]
12. Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity. Inciarte-Mundo J; Ramirez J; Hernández MV; Ruiz-Esquide V; Cuervo A; Cabrera-Villalba SR; Pascal M; Yagüe J; Cañete JD; Sanmarti R Arthritis Res Ther; 2016 Jul; 18(1):160. PubMed ID: 27391315 [TBL] [Abstract][Full Text] [Related]
13. Predicting Imaging Remission in Rheumatoid Arthritis: a Case-control Ultrasound Study. Chung SW; Choi JY; Lee SH; Song R; Yang HI; Hong SJ; Lee YA J Korean Med Sci; 2020 Aug; 35(31):e260. PubMed ID: 32776721 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression. Naredo E; Collado P; Cruz A; Palop MJ; Cabero F; Richi P; Carmona L; Crespo M Arthritis Rheum; 2007 Feb; 57(1):116-24. PubMed ID: 17266071 [TBL] [Abstract][Full Text] [Related]
15. Persistence of power Doppler ultrasonography-detected synovitis over 1 year of follow-up predicts poor prognosis in rheumatoid arthritis in clinical remission: the SONORE prospective longitudinal study. Mouterde G; Lukas C; Filippi N; Marin G; Molinari N; Combe B; Morel J RMD Open; 2024 Sep; 10(3):. PubMed ID: 39289028 [TBL] [Abstract][Full Text] [Related]
16. Relation of Doppler ultrasound synovitis versus clinical synovitis with changes in native complement component levels in rheumatoid arthritis patients treated with biologic disease-modifying anti-rheumatic drugs. Montoro Alvarez M; Chong OY; Janta I; González C; López-Longo J; Monteagudo I; Valor L; Garrido J; Lau IS; Rosman A; Naredo E; Carreño L Clin Exp Rheumatol; 2015; 33(2):141-5. PubMed ID: 25665178 [TBL] [Abstract][Full Text] [Related]
17. Disease remission state in patients treated with the combination of tumor necrosis factor blockade and methotrexate or with disease-modifying antirheumatic drugs: A clinical and imaging comparative study. Saleem B; Brown AK; Keen H; Nizam S; Freeston J; Karim Z; Quinn M; Wakefield R; Hensor E; Conaghan PG; Emery P Arthritis Rheum; 2009 Jul; 60(7):1915-22. PubMed ID: 19565512 [TBL] [Abstract][Full Text] [Related]
18. Factors influencing concordance between clinical and ultrasound findings in rheumatoid arthritis. Le Boedec M; Jousse-Joulin S; Ferlet JF; Marhadour T; Chales G; Grange L; Hacquard-Bouder C; Loeuille D; Sellam J; Albert JD; Bentin J; Chary-Valckenaere I; D'Agostino MA; Etchepare F; Gaudin P; Hudry C; Dougados M; Saraux A J Rheumatol; 2013 Mar; 40(3):244-52. PubMed ID: 23322464 [TBL] [Abstract][Full Text] [Related]
19. Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission. Terslev L; Brahe CH; Østergaard M; Fana V; Ammitzbøll-Danielsen M; Møller T; Krabbe S; Hetland ML; Døhn UM Arthritis Res Ther; 2021 Feb; 23(1):48. PubMed ID: 33522948 [TBL] [Abstract][Full Text] [Related]
20. Ultrasound-detected joint inflammation and B cell count: related variables for rituximab-treated RA patients? Valor L; Martínez-Estupiñán L; Janta I; Nieto JC; Ovalles-Bonilla JG; González-Fernández C; Del Rio T; Hernández-Flórez D; Monteagudo I; López-Longo FJ; Naredo E Rheumatol Int; 2016 Jun; 36(6):793-7. PubMed ID: 27072348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]